Literature DB >> 24872590

Restriction of HIV-1 by rhesus TRIM5α is governed by alpha helices in the Linker2 region.

Jaya Sastri1, Laura Johnsen2, Nikolai Smolin3, Sabrina Imam2, Santanu Mukherjee2, Zana Lukic4, Alberto Brandariz-Nuñez5, Seth L Robia3, Felipe Diaz-Griffero5, Christopher Wiethoff2, Edward M Campbell6.   

Abstract

UNLABELLED: TRIM5α proteins are a potent barrier to the cross-species transmission of retroviruses. TRIM5α proteins exhibit an ability to self-associate at many levels, ultimately leading to the formation of protein assemblies with hexagonal symmetry in vitro and cytoplasmic assemblies when expressed in cells. However, the role of these assemblies in restriction, the determinants that mediate their formation, and the organization of TRIM5α molecules within these assemblies have remained unclear. Here we show that α-helical elements within the Linker2 region of rhesus macaque TRIM5α govern the ability to form cytoplasmic assemblies in cells and restrict HIV-1 infection. Mutations that reduce α-helix formation by the Linker2 region disrupt assembly and restriction. More importantly, mutations that enhance the α-helical content of the Linker2 region, relative to the wild-type protein, also exhibit an increased ability to form cytoplasmic assemblies and restrict HIV-1 infection. Molecular modeling of the TRIM5α dimer suggests a model in which α-helical elements within the Linker2 region dock to α-helices of the coiled-coil domain, likely establishing proper orientation and spacing of protein domains necessary for assembly and restriction. Collectively, these studies provide critical insight into the determinants governing TRIM5α assembly and restriction and demonstrate that the antiviral potency of TRIM5α proteins can be significantly increased without altering the affinity of SPRY/capsid binding. IMPORTANCE: Many members of the tripartite motif (TRIM) family of proteins act as restriction factors that directly inhibit viral infection and activate innate immune signaling pathways. Another common feature of TRIM proteins is the ability to form protein assemblies in the nucleus or the cytoplasm. However, the determinants in TRIM proteins required for assembly and the degree to which assembly affects TRIM protein function have been poorly understood. Here we show that alpha helices in the Linker2 (L2) region of rhesus TRIM5α govern assembly and restriction of HIV-1 infection. Helix-disrupting mutations disrupt the assembly and restriction of HIV-1, while helix-stabilizing mutations enhance assembly and restriction relative to the wild-type protein. Circular dichroism analysis suggests that that the formation of this helical structure is supported by intermolecular interactions with the coiled-coil (CC) domain in the CCL2 dimer. These studies reveal a novel mechanism by which the antiviral activity of TRIM5α proteins can be regulated and provide detailed insight into the assembly determinants of TRIM family proteins.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24872590      PMCID: PMC4136267          DOI: 10.1128/JVI.01134-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

2.  The ability of multimerized cyclophilin A to restrict retrovirus infection.

Authors:  Hassan Javanbakht; Felipe Diaz-Griffero; Wen Yuan; Darwin F Yeung; Xing Li; Byeongwoon Song; Joseph Sodroski
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

3.  An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.

Authors:  Sarah Sebastian; Christian Grütter; Caterina Strambio de Castillia; Thomas Pertel; Silvia Olivari; Markus G Grütter; Jeremy Luban
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

4.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

5.  A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.

Authors:  Emi E Nakayama; Hiroyuki Miyoshi; Yoshiyuki Nagai; Tatsuo Shioda
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Identification of residues within the L2 region of rhesus TRIM5alpha that are required for retroviral restriction and cytoplasmic body localization.

Authors:  Jaya Sastri; Christopher O'Connor; Cindy M Danielson; Michael McRaven; Patricio Perez; Felipe Diaz-Griffero; Edward M Campbell
Journal:  Virology       Date:  2010-07-14       Impact factor: 3.616

7.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

9.  All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.

Authors:  Sadayuki Ohkura; Melvyn W Yap; Tom Sheldon; Jonathan P Stoye
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

10.  TRIM5 alpha cytoplasmic bodies are highly dynamic structures.

Authors:  Edward M Campbell; Mark P Dodding; Melvyn W Yap; Xiaolu Wu; Sarah Gallois-Montbrun; Michael H Malim; Jonathan P Stoye; Thomas J Hope
Journal:  Mol Biol Cell       Date:  2007-03-28       Impact factor: 4.138

View more
  6 in total

1.  TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.

Authors:  Edward M Campbell; Jared Weingart; Paola Sette; Silvana Opp; Jaya Sastri; Sarah K O'Connor; Sarah Talley; Felipe Diaz-Griffero; Vanessa Hirsch; Fadila Bouamr
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  Dynamic conformational changes in the rhesus TRIM5α dimer dictate the potency of HIV-1 restriction.

Authors:  Rajan Lamichhane; Santanu Mukherjee; Nikolai Smolin; Raymond F Pauszek; Margret Bradley; Jaya Sastri; Seth L Robia; David Millar; Edward M Campbell
Journal:  Virology       Date:  2016-11-04       Impact factor: 3.616

3.  The effect of exon 7 deletion during the evolution of TRIMCyp fusion proteins on viral restriction, cytoplasmic body formation and multimerization.

Authors:  Feng Liang Liu; Yi Qun Kuang; Dan Mu; Hong Yi Zheng; Jia Wu Zhu; Yong Tang Zheng
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

4.  Crystal structure of TRIM20 C-terminal coiled-coil/B30.2 fragment: implications for the recognition of higher order oligomers.

Authors:  Christopher Weinert; Damien Morger; Aleksandra Djekic; Markus G Grütter; Peer R E Mittl
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

5.  TRIM5α SPRY/coiled-coil interactions optimize avid retroviral capsid recognition.

Authors:  Marcin D Roganowicz; Sevnur Komurlu; Santanu Mukherjee; Jacek Plewka; Steven L Alam; Katarzyna A Skorupka; Yueping Wan; Damian Dawidowski; David S Cafiso; Barbie K Ganser-Pornillos; Edward M Campbell; Owen Pornillos
Journal:  PLoS Pathog       Date:  2017-10-17       Impact factor: 6.823

6.  Defects in assembly explain reduced antiviral activity of the G249D polymorphism in human TRIM5α.

Authors:  Sevnur Kömürlü; Margret Bradley; Nikolai Smolin; Sabrina Imam; Raymond F Pauszek; Seth L Robia; David Millar; Emi E Nakayama; Tatsuo Shioda; Edward M Campbell
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.